The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $135.88

Today's change+0.98 +0.73%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

Abiomed Inc

Nasdaq: ABMD
Last

(U.S.) $135.88

Today's change+0.98 +0.73%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.

Abiomed Inc up (U.S.)$0.98

Abiomed Inc closed up Thursday by (U.S.)$0.98 or 0.73% to (U.S.)$135.88. Over the last five days, shares have gained 1.98% and 20.59% year to date. Shares have outperformed the S&P 500 by 21.81% during the last year.

Key company metrics

  • Open(U.S.) $135.33
  • Previous close(U.S.) $134.90
  • High(U.S.) $136.74
  • Low(U.S.) $134.39
  • Bid / Ask-- / --
  • YTD % change+20.59%
  • Volume282,062
  • Average volume (10-day)313,958
  • Average volume (1-month)310,435
  • Average volume (3-month)354,690
  • 52-week range(U.S.) $95.14 to (U.S.) $137.00
  • Beta0.25
  • Trailing P/E117.02×
  • P/E 1 year forward73.75×
  • Forward PEG1.84×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.16
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2017Q3/2017Q2/2017Q1/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue125115103103
Total other revenue--------
Total revenue125115103103
Gross profit105968688
Total cost of revenue19191715
Total operating expense96898882
Selling / general / administrative60545351
Research & development16161816
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income29251521
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax29261521
Income after tax1515913
Income tax, total141069
Net income1515913
Total adjustments to net income--------
Net income before extra. items1515913
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1515913
Inc. avail. to common incl. extra. items1515913
Diluted net income1515913
Dilution adjustment0----0
Diluted weighted average shares45454545
Diluted EPS excluding extraordinary itemsvalue per share0.330.340.200.29
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.330.340.200.29